All tenders
HHSO100201500009C
IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PLASMA,AND ORAL FLUID.
Office of Assistant Secretary for Preparedness and Response · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- HHSO100201500009C
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PLASMA,AND ORAL FLUID.
- Source
- USASpending (Federal)
- Source ID
- usa-HHSO100201500009C
Details
- Location
- United States
Description
IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PLASMA,AND ORAL FLUID. Awarded to: ORASURE TECHNOLOGIES INC Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2015/06/02 12:00:00 AM UTC
- Closing date
- 2022/08/31 12:00:00 AM UTC
Estimated value
$10.6M USD
Classification
Normalized category
Other